{
  "success": true,
  "pagesUsed": [
    4,
    8,
    10,
    11,
    17,
    18,
    23,
    33,
    34,
    35,
    58
  ],
  "modelUsed": "claude-opus-4-5",
  "confidence": 1.0,
  "scheduling": {
    "timings": [
      {
        "id": "timing_1",
        "name": "Screening Window",
        "type": "Within",
        "unit": "days",
        "instanceType": "Timing",
        "value": 28,
        "relativeTo": "First Dose",
        "windowLower": -28,
        "windowUpper": -2
      },
      {
        "id": "timing_2",
        "name": "Washout Period Between Treatment Periods",
        "type": "After",
        "unit": "days",
        "instanceType": "Timing",
        "value": 7,
        "relativeTo": "Previous Visit",
        "windowLower": 7
      },
      {
        "id": "timing_3",
        "name": "Safety Follow-up Call",
        "type": "After",
        "unit": "days",
        "instanceType": "Timing",
        "value": 7,
        "relativeTo": "Last Dose",
        "windowLower": 7,
        "windowUpper": 7
      },
      {
        "id": "timing_4",
        "name": "Total Study Duration",
        "type": "Within",
        "unit": "days",
        "instanceType": "Timing",
        "value": 57,
        "relativeTo": "Study Start",
        "windowLower": 0,
        "windowUpper": 57
      },
      {
        "id": "timing_5",
        "name": "Resident at CRU Period",
        "type": "Between",
        "unit": "days",
        "instanceType": "Timing",
        "value": 2,
        "relativeTo": "First Dose",
        "windowLower": -1,
        "windowUpper": 2
      },
      {
        "id": "timing_6",
        "name": "Investigational Drug Washout Prior to Study",
        "type": "Before",
        "unit": "days",
        "instanceType": "Timing",
        "value": 60,
        "relativeTo": "First Dose",
        "windowLower": -60
      },
      {
        "id": "timing_7",
        "name": "Monoclonal Antibody Washout",
        "type": "Before",
        "unit": "years",
        "instanceType": "Timing",
        "value": 1,
        "relativeTo": "First Dose",
        "windowLower": -365
      },
      {
        "id": "timing_8",
        "name": "CYP3A4/5 or P-gp Inhibitor/Inducer Washout",
        "type": "Before",
        "unit": "weeks",
        "instanceType": "Timing",
        "value": 4,
        "relativeTo": "First Dose",
        "windowLower": -28
      },
      {
        "id": "timing_9",
        "name": "Prescription/OTC Medication Washout",
        "type": "Before",
        "unit": "weeks",
        "instanceType": "Timing",
        "value": 2,
        "relativeTo": "First Dose",
        "windowLower": -14
      },
      {
        "id": "timing_10",
        "name": "Live Vaccine Washout",
        "type": "Before",
        "unit": "months",
        "instanceType": "Timing",
        "value": 3,
        "relativeTo": "Screening",
        "windowLower": -90
      },
      {
        "id": "timing_11",
        "name": "Other Vaccine Washout",
        "type": "Before",
        "unit": "days",
        "instanceType": "Timing",
        "value": 42,
        "relativeTo": "First Dose",
        "windowLower": -42
      },
      {
        "id": "timing_12",
        "name": "Symptom-Free Period Before First Dose",
        "type": "Before",
        "unit": "weeks",
        "instanceType": "Timing",
        "value": 1,
        "relativeTo": "First Dose",
        "windowLower": -7
      },
      {
        "id": "timing_13",
        "name": "Holter Recording Start",
        "type": "Before",
        "unit": "hours",
        "instanceType": "Timing",
        "value": 1,
        "relativeTo": "First Dose",
        "windowLower": -1
      },
      {
        "id": "timing_14",
        "name": "Holter Recording Duration",
        "type": "After",
        "unit": "hours",
        "instanceType": "Timing",
        "value": 24,
        "relativeTo": "First Dose",
        "windowLower": 0,
        "windowUpper": 24
      },
      {
        "id": "timing_15",
        "name": "Treatment Period 2 Start",
        "type": "At",
        "unit": "days",
        "instanceType": "Timing",
        "value": 7,
        "relativeTo": "Study Start",
        "windowLower": 7
      },
      {
        "id": "timing_16",
        "name": "Treatment Period 3 Start",
        "type": "At",
        "unit": "days",
        "instanceType": "Timing",
        "value": 14,
        "relativeTo": "Study Start",
        "windowLower": 14
      },
      {
        "id": "timing_17",
        "name": "Treatment Period 4 Start",
        "type": "At",
        "unit": "days",
        "instanceType": "Timing",
        "value": 21,
        "relativeTo": "Study Start",
        "windowLower": 21
      },
      {
        "id": "timing_18",
        "name": "End of Treatment Assessment",
        "type": "At",
        "unit": "days",
        "instanceType": "Timing",
        "value": 23,
        "relativeTo": "Study Start",
        "windowLower": 23,
        "windowUpper": 23
      }
    ],
    "conditions": [
      {
        "id": "cond_1",
        "name": "ALT/AST Elevation Stopping Criteria",
        "instanceType": "Condition",
        "description": "Liver safety stopping criteria based on ALT or AST elevation",
        "text": "All confirmed events of ALT or AST ≥ 5 × ULN triggers stopping criteria"
      },
      {
        "id": "cond_2",
        "name": "ALT/AST with Bilirubin Elevation Stopping Criteria",
        "instanceType": "Condition",
        "description": "Combined liver function test stopping criteria",
        "text": "All confirmed events of ALT or AST ≥ 3 × ULN and total bilirubin ≥ 2 × ULN triggers stopping criteria"
      },
      {
        "id": "cond_3",
        "name": "QTcF Prolongation Stopping Criteria",
        "instanceType": "Condition",
        "description": "Cardiac safety stopping criteria based on QTcF changes",
        "text": "Changes from baseline in QTcF > 60 ms and QT/QTcF > 500 ms"
      },
      {
        "id": "cond_4",
        "name": "Severe Hypersensitivity Reaction",
        "instanceType": "Condition",
        "description": "Hypersensitivity/allergic reaction stopping criteria",
        "text": "Clinical manifestations of severe hypersensitivity reactions or signs and symptoms of severe skin reactions"
      },
      {
        "id": "cond_5",
        "name": "Eligibility Recheck",
        "instanceType": "Condition",
        "description": "Health status recheck on Day -1 of each period",
        "text": "Recheck of health status on Day -1 before each treatment period"
      }
    ],
    "conditionAssignments": [],
    "transitionRules": [
      {
        "id": "trans_1",
        "name": "Screening to Treatment Period 1",
        "instanceType": "TransitionRule",
        "transitionType": "Epoch Transition",
        "fromElementId": "epoch_screening",
        "toElementId": "epoch_treatment_p1",
        "text": "Participant must meet all eligibility criteria and be randomized to treatment sequence"
      },
      {
        "id": "trans_2",
        "name": "Treatment Period Transition",
        "instanceType": "TransitionRule",
        "transitionType": "Epoch Transition",
        "fromElementId": "epoch_treatment_period",
        "toElementId": "epoch_next_treatment_period",
        "text": "At least 7-day washout period between successive doses required before next treatment period"
      },
      {
        "id": "trans_3",
        "name": "Discontinuation for Liver Safety",
        "instanceType": "TransitionRule",
        "transitionType": "Discontinuation",
        "text": "ALT or AST ≥ 5 × ULN or ALT/AST ≥ 3 × ULN with total bilirubin ≥ 2 × ULN requires treatment discontinuation"
      },
      {
        "id": "trans_4",
        "name": "Discontinuation for Cardiac Safety",
        "instanceType": "TransitionRule",
        "transitionType": "Discontinuation",
        "text": "QTcF > 60 ms change from baseline and QT/QTcF > 500 ms requires investigator review for continuation"
      },
      {
        "id": "trans_5",
        "name": "Discontinuation for Hypersensitivity",
        "instanceType": "TransitionRule",
        "transitionType": "Discontinuation",
        "text": "Severe hypersensitivity reactions or severe skin reactions require participant discontinuation from study"
      },
      {
        "id": "trans_6",
        "name": "Discontinuation for Pregnancy",
        "instanceType": "TransitionRule",
        "transitionType": "Discontinuation",
        "text": "Pregnancy requires discontinuation of study intervention"
      },
      {
        "id": "trans_7",
        "name": "Discontinuation for Severe AE",
        "instanceType": "TransitionRule",
        "transitionType": "Discontinuation",
        "text": "AEs of severe intensity and SAEs regardless of relationship to study intervention may require discontinuation"
      },
      {
        "id": "trans_8",
        "name": "Discontinuation for Protocol Noncompliance",
        "instanceType": "TransitionRule",
        "transitionType": "Discontinuation",
        "text": "Protocol noncompliance judged as significant by the Investigator after discussion with Sponsor"
      },
      {
        "id": "trans_9",
        "name": "Discontinuation for Prohibited Medication Use",
        "instanceType": "TransitionRule",
        "transitionType": "Discontinuation",
        "text": "Use of nonpermitted concomitant drug if clinically relevant as agreed by Sponsor and Investigator"
      }
    ],
    "scheduleTimelineExits": [
      {
        "id": "exit_1",
        "name": "Participant Withdrawal of Consent",
        "exitType": "Early Termination",
        "instanceType": "ScheduleTimelineExit",
        "description": "Participant may discontinue from the study at any time at his/her own request"
      },
      {
        "id": "exit_2",
        "name": "Investigator Discretion Discontinuation",
        "exitType": "Early Termination",
        "instanceType": "ScheduleTimelineExit",
        "description": "Discontinuation at discretion of Investigator for safety, behavioral, compliance, or administrative reasons"
      },
      {
        "id": "exit_3",
        "name": "Study Completion",
        "exitType": "Completion",
        "instanceType": "ScheduleTimelineExit",
        "description": "Completion of all 4 treatment periods and Safety Follow-up call on Day 29"
      },
      {
        "id": "exit_4",
        "name": "Lost to Follow-Up",
        "exitType": "Early Termination",
        "instanceType": "ScheduleTimelineExit",
        "description": "Participant repeatedly fails to return for scheduled visits and is unable to be contacted by study site"
      },
      {
        "id": "exit_5",
        "name": "Eligibility Criteria Not Met Post-Enrollment",
        "exitType": "Early Termination",
        "instanceType": "ScheduleTimelineExit",
        "description": "Participant enrolled but subsequently discovered not to have met inclusion/exclusion criteria at Screening"
      },
      {
        "id": "exit_6",
        "name": "Study Termination by Sponsor",
        "exitType": "Early Termination",
        "instanceType": "ScheduleTimelineExit",
        "description": "Sponsor discontinuation due to unacceptable risk, relevant toxicity, or negative change in risk/benefit assessment"
      }
    ],
    "scheduledDecisionInstances": [
      {
        "id": "dec_1",
        "name": "Day -1 Eligibility Recheck Decision",
        "timepointId": "day_minus_1_each_period",
        "instanceType": "ScheduledDecisionInstance",
        "description": "Decision point for confirming participant health status before each treatment period",
        "conditionIds": [
          "cond_5"
        ]
      },
      {
        "id": "dec_2",
        "name": "Cardiac Safety Review Decision",
        "timepointId": "post_dose_ecg_review",
        "instanceType": "ScheduledDecisionInstance",
        "description": "Investigator determines if participant can continue in study based on QTcF findings",
        "conditionIds": [
          "cond_3"
        ]
      },
      {
        "id": "dec_3",
        "name": "Liver Safety Review Decision",
        "timepointId": "lab_safety_review",
        "instanceType": "ScheduledDecisionInstance",
        "description": "Investigator considers discontinuation for abnormal liver function based on algorithm",
        "conditionIds": [
          "cond_1",
          "cond_2"
        ]
      }
    ],
    "summary": {
      "timingCount": 18,
      "conditionCount": 5,
      "transitionRuleCount": 9,
      "exitCount": 6
    }
  }
}